186429-59-4

Basic information

• Product Name: L-Phenylalanine, N-[(5-chloro-1H-indol-2-yl)carbonyl]-, methyl ester
• CAS NO: 186429-59-4
• Molecular Formula: C19H17ClN2O3
• Molecular Weight: 356.809
• Mol File: 186429-59-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: L-Phenylalanine, N-[(5-chloro-1H-indol-2-yl)carbonyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine, N-[(5-chloro-1H-indol-2-yl)carbonyl]-, methyl ester(186429-59-4)
• EPA Substance Registry System: L-Phenylalanine, N-[(5-chloro-1H-indol-2-yl)carbonyl]-, methyl ester(186429-59-4)

Safety Data

• Hazardous Substances Data: 186429-59-4(Hazardous Substances Data)

Upstream product

• 10517-21-2 5-chloro-1H-Indole-2-carboxylic acid 
• 7524-50-7 methyl (2S)-2-amino-3-phenylpropanoate hydrochloride 

Relevant articles and documents

Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase [3]

-

Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors

PCT No. PCT/IB95/00442 Sec. 371 Date Dec. 2, 1997 Sec. 102(e) Date Dec. 2, 1997 PCT Filed Jun. 6, 1995 PCT Pub. No. WO96/39384 PCT Pub. Date Dec. 12, 1996Compounds of Formula (1) wherein R6 is carboxy, (C1-C8)alkoxycarbonyl, benzyloxycarbonyl, C(O)NR8R9 or C(O)R12 as glucogen phosphorylase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals.